FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hubert Pehamberger

Research Profile

Disorders

Living Beings

Anatomy

Chemicals & Drugs

Procedures

Physiology

Cell Divisions

Concepts & Ideas

Neoplasm Staging

Co-author Network

Publications

TOP 3
Clemens Krepler; Mark McKinlay; Yasuhiro Mitsuuchi; Katherine L Nathanson; Eric M Neiman; Hubert Pehamberger; Jessie Villanueva; Adina Vultur; Min Xiao; Ravi K Amaravadi; Christopher Benetatos; Srinivas K Chunduru; Molly B Halloran; Xu He; Meenhard Herlyn
The novel SMAC mimetic birinapant exhibits potent activity against human melanoma cells.
Aneesh Alex; Michael Binder; Marcel Kellner-Höfer; Karsten König; Romina Nemecek; Hubert Pehamberger; Jessika Weingast; Martin Weinigel; Wolfgang Drexler
Three-dimensional multiphoton/optical coherence tomography for diagnostic applications in dermatology.
Philipp Tschandl; Hubert Pehamberger; Harald Kittler
Trends in the diagnosis of melanoma at a university center over time.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hubert Pehamberger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Clemens Krepler; Mark McKinlay; Yasuhiro Mitsuuchi; Katherine L Nathanson; Eric M Neiman; Hubert Pehamberger; Jessie Villanueva; Adina Vultur; Min Xiao; Ravi K Amaravadi; Christopher Benetatos; Srinivas K Chunduru; Molly B Halloran; Xu He; Meenhard Herlyn
The novel SMAC mimetic birinapant exhibits potent activity against human melanoma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(7):1784-94.
2013: Aneesh Alex; Michael Binder; Marcel Kellner-Höfer; Karsten König; Romina Nemecek; Hubert Pehamberger; Jessika Weingast; Martin Weinigel; Wolfgang Drexler
Three-dimensional multiphoton/optical coherence tomography for diagnostic applications in dermatology.
Journal of biophotonics 2013;6(4):352-62.
2013: Philipp Tschandl; Hubert Pehamberger; Harald Kittler
Trends in the diagnosis of melanoma at a university center over time.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2013;11(3):251-6.
2013: Peter Valent; Friedrich Wimazal; Stefan Wöhrl; Brigitte Zahel; Wolfgang R Sperr; Elisabeth Aberer; Christine Beham-Schmid; Christina Fellinger; Wolfgang Fuchs; Karoline V Gleixner; Rosemarie Greul; Emir Hadzijusufovic; Gregor Hoermann; Hubert Pehamberger
Guidelines and diagnostic algorithm for patients with suspected systemic mastocytosis: a proposal of the Austrian competence network (AUCNM).
American journal of blood research 2013;3(2):174-80.
2013: Jean Jacques Grob; Bernard Guillot; Ralf Gutzmer; Axel Hauschild; Rudolf A Herbst; Thomas Jouary; Michael Landthaler; Marie Thérèse Leccia; Julien Asselineau; Genevieve Chene; Brigitte Dréno; Claus Garbe; Bruno Sassolas; Hubert Pehamberger
Adjuvant therapy with pegylated interferon alfa-2b (36 months) versus low-dose interferon alfa-2b (18 months) in melanoma patients without macrometastatic nodes: an open-label, randomised, phase 3 European Association for Dermato-Oncology (EADO) study.
European journal of cancer (Oxford, England : 1990) 2013;49(1):166-74.
2013: Andreas Bracher; Ana Soler Cardona; Astrid M Fink; Marion Gröger; Heide Niederleithner; Hubert Pehamberger; peter petzelbauer; Andreas Steiner; Stefanie Tauber; Robert Loewe
Epidermal growth factor facilitates melanoma lymph node metastasis by influencing tumor lymphangiogenesis.
The Journal of investigative dermatology 2013;133(1):230-8.
2012: Claus Garbe; Jean-Jacques Grob; Axel Hauschild; Josep Malvehy; Mark Middleton; Julia Newton-Bishop; Hubert Pehamberger; Ketty Peris; philippe saiag; Alan Spatz; Alexander Stratigos; Alexander M Eggermont
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline--Update 2012.
European journal of cancer (Oxford, England : 1990) 2012;48(15):2375-90.
2012: Heide Niederleithner; Hubert Pehamberger; Stefan Sonderegger; Stefanie Tauber; Walter Berger; Martin Bilban; Andreas Bracher; Magdalena Heinz; Martin Knöfler; Robert Loewe; peter petzelbauer
Wnt1 is anti-lymphangiogenic in a melanoma mouse model.
The Journal of investigative dermatology 2012;132(9):2235-44.
2012: Katja Schindler; Michael Toepker; Andrea Haitel; Christoph Hoeller; Rainer Kunstfeld; Hubert Pehamberger; Nikolaus Schicher; Kaan Harmankaya
A rare case of primary rhabdoid melanoma of the urinary bladder treated with ipilimumab, an anti-CTLA 4 monoclonal antibody.
Melanoma research 2012;22(4):320-5.
2012: Judith Wendt; Michael Binder; Hubert Pehamberger; Oliver Schanab; Ichiro Okamoto
Site-dependent actinic skin damage as risk factor for melanoma in a central European population.
Pigment cell & melanoma research 2012;25(2):234-42.
2012: Verena Paulitschke; Hubert Pehamberger; peter petzelbauer; Nikolaus Schicher; Christopher Gerner; Silke Gruber; Verena Haudek-Prinz; Elisabeth Hofstätter; Constanze Jonak; Philipp Klepeisz; Rainer Kunstfeld
Proteome analysis identified the PPARγ ligand 15d-PGJ2 as a novel drug inhibiting melanoma progression and interfering with tumor-stroma interaction.
PloS one 2012;7(9):e46103.
2011: Julia Valencak; Werner Wallnöfer; Katharina Schmid; Afschin Soleiman; Franz Trautinger; Andrea Haitel; Robert Knobler; Leonhard Muellauer; Hubert Pehamberger; Markus Raderer
High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
Journal of dermatological science 2011;64(3):185-90.
2011: Kaan Harmankaya; Axel Hoos; Ramy Ibrahim; Claus Koelblinger; Hubert Pehamberger; Christa Erasim; Michael Binder
Continuous systemic corticosteroids do not affect the ongoing regression of metastatic melanoma for more than two years following ipilimumab therapy.
Medical oncology (Northwood, London, England) 2011;28(4):1140-4.
2011: Alexander Swoboda; Ichiro Okamoto; Hubert Pehamberger; peter petzelbauer; Doris Rasin-Streden; Oliver Schanab; Mario Mikula
Identification of genetic disparity between primary and metastatic melanoma in human patients.
Genes, chromosomes & cancer 2011;50(9):680-8.
2011: Oliver Schanab; Sanda Sturlan; Andreas Gleiss; Susanne Grunt; Johannes Humer; Mario Mikula; Thomas Muster; Ichiro Okamoto; Hubert Pehamberger; Andrea Waltenberger
Expression of human endogenous retrovirus K is stimulated by ultraviolet radiation in melanoma.
Pigment cell & melanoma research 2011;24(4):656-65.
2011: Manon Der-Petrossian; Claudia Jonak; Gabriele Klosner; Robert Knobler; Leonhard Müllauer; Hubert Pehamberger; T Dani; Julia Valencak; Franz Trautinger
Dermal infiltrates of cutaneous T-cell lymphomas with epidermotropism but not other cutaneous lymphomas are abundant with langerin⁺ dendritic cells.
Journal of the European Academy of Dermatology and Venereology : JEADV 2011;25(8):922-7.
2011: Julia Latzka; Sonja Gaier; Gerlinde Hofstetter; Nina Balazs; Ursula Smole; Soldano Ferrone; Otto Scheiner; Heimo Breiteneder; Hubert Pehamberger; Stefan Wagner
Specificity of mimotope-induced anti-high molecular weight-melanoma associated antigen (HMW-MAA) antibodies does not ensure biological activity.
PloS one 2011;6(5):e19383.
2011: Constanze Jonak; Michael Mildner; Gabriele Klosner; Verena Paulitschke; Rainer Kunstfeld; Hubert Pehamberger; Erwin Tschachler; Franz Trautinger
The hsp27kD heat shock protein and p38-MAPK signaling are required for regular epidermal differentiation.
Journal of dermatological science 2011;61(1):32-7.
2010: Martin Bilban; S Tauber; Peter Haslinger; Jürgen Pollheimer; Leila Saleh; Hubert Pehamberger; Oswald Wagner; Martin Knöfler
Trophoblast invasion: assessment of cellular models using gene expression signatures.
Placenta 2010;31(11):989-96.
2010: Axel Schulenburg; Kira Brämswig; Harald Herrmann; Heidrun Karlic; Irina Mirkina; Rainer Hubmann; Sylvia Laffer; Brigitte Marian; Medhat Shehata; Clemens Krepler; Hubert Pehamberger; Thomas Grunt; Ulrich Jäger; Christoph C Zielinski; Peter Valent
Neoplastic stem cells: current concepts and clinical perspectives.
Critical reviews in oncology/hematology 2010;76(2):79-98.
2010: Alexandra Böhm; Karoline Sonneck; Karoline V Gleixner; Karina Schuch; Winfried F Pickl; Katharina Blatt; Barbara Peter; Harald Herrmann; Gerit-Holger Schernthaner; Hubert Pehamberger; Werner Rabitsch; Wolfgang R Sperr; Peter Valent
In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816V.
Experimental hematology 2010;38(9):744-55.
2010: Heidrun Karlic; Harald Herrmann; Axel Schulenburg; Thomas W Grunt; Sylvia Laffer; Irina Mirkina; Rainer Hubmann; Medhat Shehata; Brigitte Marian; Edgar Selzer; Michael Pfeilstöcker; Elisabeth Pittermann; Ulrich Jäger; Hubert Pehamberger; Christoph Zielinski; Peter Valent
[Tumor stem cell research - basis and challenge for diagnosis and therapy].
Wiener klinische Wochenschrift 2010;122(13-14):423-36.
2010: Verena Paulitschke; Nikolaus Schicher; Thomas Szekeres; Walter Jäger; Leonilla Elbling; Angelika B Riemer; Otto Scheiner; Golakoti Trimurtulu; Somepalli Venkateswarlu; Mario Mikula; Alexander Swoboda; Edda Fiebiger; Christopher Gerner; Hubert Pehamberger; Rainer Kunstfeld
3,3',4,4',5,5'-hexahydroxystilbene impairs melanoma progression in a metastatic mouse model.
The Journal of investigative dermatology 2010;130(6):1668-79.
2010: Verena Leitner; Jessika Weingast; Kaan Harmankaya; Julia Walochnik; Hubert Pehamberger; peter petzelbauer; Herbert Auer; Michael Binder
Leishmaniasis in the tongue of an immunocompetent man.
The American journal of tropical medicine and hygiene 2010;82(4):597-9.
2010: Teresa Valero; Silvia Steele; Karin Neumüller; Andreas Bracher; Heide Niederleithner; Hubert Pehamberger; peter petzelbauer; Robert Loewe
Combination of dacarbazine and dimethylfumarate efficiently reduces melanoma lymph node metastasis.
The Journal of investigative dermatology 2010;130(4):1087-94.
2010: Margit A Huber; Norbert Kraut; Jeffrey B Madwed; Harald J Maier; Daniel R Marshall; Hubert Pehamberger; Eva Wiedemann; Thomas Wirth; Erick R R Young; Memetcan Alacakaptan; Guido Boehmelt; Jürgen Braunger; Hartmut Beug
BI 5700, a Selective Chemical Inhibitor of IκB Kinase 2, Specifically Suppresses Epithelial-Mesenchymal Transition and Metastasis in Mouse Models of Tumor Progression.
Genes & cancer 2010;1(2):101-14.
2010: Ursula Wiedermann; Christoph Wiltschke; Joanna Jasinska; Michael Kundi; R Zurbriggen; E Garner-Spitzer; Rupert Bartsch; Günther Steger; Hubert Pehamberger; Otto Scheiner; Christoph C Zielinski
A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study.
Breast cancer research and treatment 2010;119(3):673-83.
2010: Stefanie Tauber; Alexander Jais; Markus Jeitler; Sandra Haider; Julia Husa; Josefine Lindroos; Martin Knöfler; Matthias Mayerhofer; Hubert Pehamberger; Oswald Wagner; Martin Bilban
Transcriptome analysis of human cancer reveals a functional role of heme oxygenase-1 in tumor cell adhesion.
Molecular cancer 2010;9():200.
2010: Claus Garbe; Ketty Peris; Axel Hauschild; philippe saiag; Mark Middleton; Alain Spatz; Jean-Jacques Grob; Josep Malvehy; Julia Newton-Bishop; Alexander Stratigos; Hubert Pehamberger; Alexander Eggermont
Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline.
European journal of cancer (Oxford, England : 1990) 2010;46(2):270-83.
2009: Julia Valencak; Harald Kittler; Katharina Schmid; Martin Schreiber; Markus Raderer; M Gonzalez-Inchaurraga; Peter Birner; Hubert Pehamberger
Prognostic relevance of hypoxia inducible factor-1alpha expression in patients with melanoma.
Clinical and experimental dermatology 2009;34(8):e962-4.
2009: Nikolaus Schicher; Verena Paulitschke; Alexander Swoboda; Rainer Kunstfeld; Robert Loewe; Peter Pilarski; Hubert Pehamberger; Christoph Hoeller
Erlotinib and bevacizumab have synergistic activity against melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(10):3495-502.
2009: Verena Paulitschke; Rainer Kunstfeld; Thomas Mohr; Astrid Slany; Michael Micksche; Johannes Drach; Christoph Zielinski; Hubert Pehamberger; Christopher Gerner
Entering a new era of rational biomarker discovery for early detection of melanoma metastases: secretome analysis of associated stroma cells.
Journal of proteome research 2009;8(5):2501-10.
2009: Johannes Werzowa; D Cejka; T Fuereder; B Dekrout; Christiane Thallinger; Hubert Pehamberger; Volker Wacheck; Barbara Pratscher
Suppression of mTOR complex 2-dependent AKT phosphorylation in melanoma cells by combined treatment with rapamycin and LY294002.
The British journal of dermatology 2009;160(5):955-64.
2008: Eggert Stockfleth; Carlos Ferrandiz; Jean Jacques Grob; Irene Leigh; Hubert Pehamberger; Helmut Kerl
Development of a treatment algorithm for actinic keratoses: a European Consensus.
European journal of dermatology : EJD 2008;18(6):651-9.
2008: Johannes Humer; Boris Ferko; Andrea Waltenberger; Ronald Rapberger; Hubert Pehamberger; Thomas Muster
Azidothymidine inhibits melanoma cell growth in vitro and in vivo.
Melanoma research 2008;18(5):314-21.
2008: Martin Stichenwirth; Elisabeth Riedl; Hubert Pehamberger; Gerhard Tappeiner
Pyoderma gangrenosum in a patient with seronegative rheumatoid arthritis during therapy with adalimumab: toxic effects of adalimumab or failure of adalimumab to prevent the onset of this phenomenon?
Archives of dermatology 2008;144(6):817-8.
2008: Hubert Pehamberger; Sekretär Kunstfeld
[Austrian Society for Dermatology and Venereology OGDV]].
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2008;6(3):259.
2008: Barbara Pratscher; Cornelia Friedrich; Wilfried Goger; Matthew Allen; Dieter Fink; Christiane Thallinger; Markus F Wolschek; Klemens Frei; Christian Schöfer; Hubert Pehamberger; Volker Wacheck; Poul H B Sorensen; Markus Müller; Burkhard Jansen; Trevor Lucas
Characterization of NKIP: a novel, Na+/K+-ATPase interacting protein mediates neural differentiation and apoptosis.
Experimental cell research 2008;314(3):463-77.
2008: Florian Roka; P Mastan; Michael Binder; Ichiro Okamoto; Martina Mittlboeck; Reinhard Horvat; Hubert Pehamberger; Elisabeth Diem
Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2008;34(1):82-8.
2007: Stefan Wagner; Joanna Jasinska; Heimo Breiteneder; Michael Kundi; Hubert Pehamberger; Otto Scheiner; Christoph C Zielinski; Ursula Wiedermann
Delayed tumor onset and reduced tumor growth progression after immunization with a Her-2/neu multi-peptide vaccine and IL-12 in c-neu transgenic mice.
Breast cancer research and treatment 2007;106(1):29-38.
2007: Angelika B Riemer; Eva Untersmayr; Regina Knittelfelder; Albert Duschl; Hubert Pehamberger; Christoph C Zielinski; Otto Scheiner; Erika Jensen-Jarolim
Active induction of tumor-specific IgE antibodies by oral mimotope vaccination.
Cancer research 2007;67(7):3406-11.
2007: Sonja Hirschl; Oliver Schanab; Heide Seppele; Andrea Waltenberger; Johannes Humer; Klaus Wolff; Hubert Pehamberger; Thomas Muster
Sequence variability of retroviral particles derived from human melanoma cells melanoma-associated retrovirus.
Virus research 2007;123(2):211-5.
2006: Robert Loewe; Teresa Valero; Silvia Kremling; Barbara Pratscher; Rainer Kunstfeld; Hubert Pehamberger; peter petzelbauer
Dimethylfumarate impairs melanoma growth and metastasis.
Cancer research 2006;66(24):11888-96.
2006: Agop Bedikian; Michael Millward; Hubert Pehamberger; Robert Conry; Martin Gore; Uwe Trefzer; Anna C Pavlick; Ronald C DeConti; Evan M Hersh; Peter Hersey; John M Kirkwood; Frank G Haluska
Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(29):4738-45.
2006: Ichiro Okamoto; Florian Roka; Julia Krögler; Georg Endler; Stefan Kaufmann; Silvia Tockner; Claudia Marsik; Bernd Jilma; Christine Mannhalter; Oswald Wagner; Hubert Pehamberger
The EGF A61G polymorphism is associated with disease-free period and survival in malignant melanoma.
The Journal of investigative dermatology 2006;126(10):2242-6.
2006: Ichiro Okamoto; Julia Krögler; Georg Endler; Stefan Kaufmann; Stefan Mustafa; Markus Exner; Christine Mannhalter; Oswald Wagner; Hubert Pehamberger
A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with risk for melanoma.
International journal of cancer. Journal international du cancer 2006;119(6):1312-5.
2006: Angelika B Riemer; Elisabeth Förster-Waldl; Kira H Brämswig; Arnold Pollak; Christoph C Zielinski; Hubert Pehamberger; Holger N Lode; Otto Scheiner; Erika Jensen-Jarolim
Induction of IgG antibodies against the GD2 carbohydrate tumor antigen by vaccination with peptide mimotopes.
European journal of immunology 2006;36(5):1267-74.
2006: Johannes Humer; Andrea Waltenberger; Andreas Grassauer; Martin Kurz; Julia Valencak; Ronald Rapberger; Silvia Hahn; Roswitha Löwer; Klaus Wolff; Michael Bergmann; Thomas Muster; Bernd Mayer; Hubert Pehamberger
Identification of a melanoma marker derived from melanoma-associated endogenous retroviruses.
Cancer research 2006;66(3):1658-63.
2006: Margit A Huber; Norbert Kraut; Norbert Schweifer; Helmut Dolznig; Ralf Uwe Peter; Roland D Schubert; Karin Scharffetter-Kochanek; Hubert Pehamberger; Pilar Garin-Chesa
Expression of stromal cell markers in distinct compartments of human skin cancers.
Journal of cutaneous pathology 2006;33(2):145-55.
2006: Margit A Huber; Gyde Staib; Hubert Pehamberger; Karin Scharffetter-Kochanek
Management of refractory early-stage cutaneous T-cell lymphoma.
American journal of clinical dermatology 2006;7(3):155-69.
2005: Julia Valencak; Elisabeth Heere-Ress; Tatjana Traub-Weidinger; Markus Raderer; Achim Schneeberger; Theresia Thalhammer; Sylvia Aust; Gerhard Hamilton; Irene Virgolini; Hubert Pehamberger
Somatostatin receptor scintigraphy with 111In-DOTA-lanreotide and 111In-DOTA-Tyr3-octreotide in patients with stage IV melanoma: in-vitro and in-vivo results.
Melanoma research 2005;15(6):523-9.
2005: Matthew Allen; Barbara Pratscher; Clemens Krepler; Klemens Frei; Christian Schöfer; Hubert Pehamberger; Markus Müller; Trevor Lucas
Alternative splicing of IL-24 in melanocytes by deletion of exons 3 and 5.
International journal of immunogenetics 2005;32(6):375-8.
2005: Erika Richtig; Hans Peter Soyer; Martin Posch; Ulrike Mossbacher; Peter Bauer; Ligia Teban; Gerhard Svolba; Ingrid H Wolf; Peter Fritsch; Bernhard Zelger; Beatrix Volc-Platzer; Walter Gebhart; Paul Mischer; Andreas Steiner; Wolf Pachinger; Helmut Hintner; Friedrich Gschnait; Klemens Rappersberger; Peter Pilarski; Hubert Pehamberger
Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(34):8655-63.
2005: Georg Duftschmid; Michael Binder; Thomas Wrba; Wolfgang Dorda; Hubert Pehamberger
[Guidelines for the planning and implementation of telemedical applications].
Wiener klinische Wochenschrift 2005;117(19-20):673-83.
2005: Trevor Lucas; Barbara Pratscher; Dieter Fink; Markus F Wolschek; Puchit Samorapoompichit; Christian Schöfer; Hubert Pehamberger; Markus Müller; Poul Sorensen; Burkhard Jansen
The human orthologue of a novel apoptosis response gene induced during rat myelomonocytic stem cell apoptosis maps to 20q13.12.
Stem cells and development 2005;14(5):556-63.
2005: Elisabeth Heere-Ress; Johannes Boehm; Christiane Thallinger; Christoph Hoeller; Volker Wacheck; Peter Birner; Klaus Wolff; Hubert Pehamberger; Burkhard Jansen
Thalidomide enhances the anti-tumor activity of standard chemotherapy in a human melanoma xenotransplatation model.
The Journal of investigative dermatology 2005;125(2):201-6.
2005: Hans Skvara; Christiane Thallinger; Volker Wacheck; Brett P Monia; Hubert Pehamberger; Burkhard Jansen; Edgar Selzer
Mcl-1 blocks radiation-induced apoptosis and inhibits clonogenic cell death.
Anticancer research 2005;25(4):2697-703.
2005: Angelika B Riemer; Brigitte Hantusch; Barbara Sponer; Georg Kraml; Christine Hafner; Christoph C Zielinski; Otto Scheiner; Hubert Pehamberger; Erika Jensen-Jarolim
High-molecular-weight melanoma-associated antigen mimotope immunizations induce antibodies recognizing melanoma cells.
Cancer immunology, immunotherapy : CII 2005;54(7):677-84.
2005: Christoph Hoeller; Barbara Pratscher; Christiane Thallinger; Dorian Winter; Dieter Fink; Boris Kovacic; Veronika Sexl; Volker Wacheck; Martin E Gleave; Hubert Pehamberger; Burkhard Jansen
Clusterin regulates drug-resistance in melanoma cells.
The Journal of investigative dermatology 2005;124(6):1300-7.
2005: Christoph Hoeller; Christiane Thallinger; Barbara Pratscher; Malena D Bister; Nikolaus Schicher; Robert Loewe; Elisabeth Heere-Ress; Florian Roka; Veronika Sexl; Hubert Pehamberger
The non-receptor-associated tyrosine kinase Syk is a regulator of metastatic behavior in human melanoma cells.
The Journal of investigative dermatology 2005;124(6):1293-9.
2005: Christine Hafner; Heimo Breiteneder; Soldano Ferrone; Christiane Thallinger; Stefan Wagner; Wolfgang M Schmidt; Joanna Jasinska; Michael Kundi; Klaus Wolff; Christoph C Zielinski; Otto Scheiner; Ursula Wiedermann; Hubert Pehamberger
Suppression of human melanoma tumor growth in SCID mice by a human high molecular weight-melanoma associated antigen (HMW-MAA) specific monoclonal antibody.
International journal of cancer. Journal international du cancer 2005;114(3):426-32.
2005: Ichiro Okamoto; Christine Pirker; Martin Bilban; Walter Berger; Doris Losert; Christine Marosi; Oskar A Haas; Klaus Wolff; Hubert Pehamberger
Seven novel and stable translocations associated with oncogenic gene expression in malignant melanoma.
Neoplasia (New York, N.Y.) 2005;7(4):303-11.
2005: Christine Hafner; Stefan Wagner; Dorothee Allwardt; Angelika B Riemer; Otto Scheiner; Hubert Pehamberger; Heimo Breiteneder
Cross-reactivity of mimotopes with a monoclonal antibody against the high molecular weight melanoma-associated antigen (HMW-MAA) does not predict cross-reactive immunogenicity.
Melanoma research 2005;15(2):111-7.
2005: Florian Roka; Harald Kittler; P Cauzig; Christoph Hoeller; Gabriele Hinterhuber; Klaus Wolff; Hubert Pehamberger; Elisabeth Diem
Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.
British journal of cancer 2005;92(4):662-7.
2005: Elisabeth Förster-Waldl; Angelika B Riemer; Anna Katharina Dehof; Dirk Neumann; Kira H Brämswig; George Boltz-Nitulescu; Hubert Pehamberger; Christoph C Zielinski; Otto Scheiner; Arnold Pollak; Holger Lode; Erika Jensen-Jarolim
Isolation and structural analysis of peptide mimotopes for the disialoganglioside GD2, a neuroblastoma tumor antigen.
Molecular immunology 2005;42(3):319-25.
2005: Stefan Wagner; Christine Hafner; Dorothee Allwardt; Joanna Jasinska; Soldano Ferrone; Christoph C Zielinski; Otto Scheiner; Ursula Wiedermann; Hubert Pehamberger; Heimo Breiteneder
Vaccination with a human high molecular weight melanoma-associated antigen mimotope induces a humoral response inhibiting melanoma cell growth in vitro.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(2):976-82.
2005: Christine Hafner; Stefan Wagner; Joanna Jasinska; Dorothee Allwardt; Otto Scheiner; Klaus Wolff; Hubert Pehamberger; Ursula Wiedermann; Heimo Breiteneder
Epitope-specific antibody response to Mel-CAM induced by mimotope immunization.
The Journal of investigative dermatology 2005;124(1):125-31.
2004: Monika Heidemarie Seltenhammer; Elisabeth Heere-Ress; Sabine Brandt; Thomas Druml; Burkhard Jansen; Hubert Pehamberger; Gert Willhelm Niebauer
Comparative histopathology of grey-horse-melanoma and human malignant melanoma.
Pigment cell research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society 2004;17(6):674-81.
2004: Clemens Krepler; Ulrich Certa; Volker Wacheck; Burkhard Jansen; Klaus Wolff; Hubert Pehamberger
Pegylated and conventional interferon-alpha induce comparable transcriptional responses and inhibition of tumor growth in a human melanoma SCID mouse xenotransplantation model.
The Journal of investigative dermatology 2004;123(4):664-9.
2004: Matthew Allen; Barbara Pratscher; Florian Roka; Clemens Krepler; Volker Wacheck; Christian Schöfer; Hubert Pehamberger; Markus Müller; Trevor Lucas
Loss of novel mda-7 splice variant (mda-7s) expression is associated with metastatic melanoma.
The Journal of investigative dermatology 2004;123(3):583-8.
2004: Margit A Huber; Ninel Azoitei; Bernd Baumann; stefan gruenert; Andreas Sommer; Hubert Pehamberger; Norbert Kraut; Hartmut Beug; Thomas Wirth
NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.
The Journal of clinical investigation 2004;114(4):569-81.
2004: Erika Richtig; Rainer Hofmann-Wellenhof; Hubert Pehamberger; Ch Forstinger; Klaus Wolff; Paul Mischer; J Raml; Peter Fritsch; Bernhard Zelger; G Ratzinger; J Koller; A Lang; K Konrad; E Kindermann-Glebowski; A Seeber; Andreas Steiner; R Fialla; Wolf Pachinger; C Kos; G Klein; H Kehrer; Helmut Kerl; H Ulmer; Josef Smolle
Temozolomide and interferon alpha 2b in metastatic melanoma stage IV.
The British journal of dermatology 2004;151(1):91-8.
2004: Angelika B Riemer; Markus Klinger; Stefan Wagner; Astrid Bernhaus; Luca Mazzucchelli; Hubert Pehamberger; Otto Scheiner; Christoph C Zielinski; Erika Jensen-Jarolim
Generation of Peptide mimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2/neu.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(1):394-401.
2004: Christiane Thallinger; Markus F Wolschek; Helmut Maierhofer; Hans Skvara; Hubert Pehamberger; Brett P Monia; Burkhard Jansen; Volker Wacheck; Edgar Selzer
Mcl-1 is a novel therapeutic target for human sarcoma: synergistic inhibition of human sarcoma xenotransplants by a combination of mcl-1 antisense oligonucleotides with low-dose cyclophosphamide.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(12 Pt 1):4185-91.
2004: Thomas Muster; Julia Rajtarova; Monika Sachet; Hermann Unger; Reinhard Fleischhacker; Ingrid Romirer; Andreas Grassauer; Angelika Url; Adolfo García-Sastre; Klaus Wolff; Hubert Pehamberger; Michael Bergmann
Interferon resistance promotes oncolysis by influenza virus NS1-deletion mutants.
International journal of cancer. Journal international du cancer 2004;110(1):15-21.
2004: Trevor Lucas; Doris Losert; Matthew Allen; Julius Halaschek-Wiener; Barbara Pratscher; Cornelia Friedrich; Markus F Wolschek; Gabriele Fuchsjäger-Mayrl; Leopold Schmetterer; Hubert Pehamberger; Markus Müller; Volker Wacheck
Combination allele-specific real-time PCR for differentiation of beta 2-adrenergic receptor coding single-nucleotide polymorphisms.
Clinical chemistry 2004;50(4):769-72.
2004: Clemens Krepler; Volker Wacheck; Sabine Strommer; Gunther Hartmann; Peter Polterauer; Klaus Wolff; Hubert Pehamberger; Burkhard Jansen
CpG oligonucleotides elicit antitumor responses in a human melanoma NOD/SCID xenotransplantation model.
The Journal of investigative dermatology 2004;122(2):387-91.
2004: Julia Valencak; Elisabeth Heere-Ress; Tamara Kopp; Sebastian F Schoppmann; Harald Kittler; Hubert Pehamberger
Selective immunohistochemical staining shows significant prognostic influence of lymphatic and blood vessels in patients with malignant melanoma.
European journal of cancer (Oxford, England : 1990) 2004;40(3):358-64.
2004: Johannes Winkler; Ernst Urban; Doris Losert; Volker Wacheck; Hubert Pehamberger; Christian R Noe
A novel concept for ligand attachment to oligonucleotides via a 2'-succinyl linker.
Nucleic acids research 2004;32(2):710-8.
2003: Joanna Jasinska; Stefan Wagner; Christian Radauer; Roland Sedivy; Thomas Brodowicz; Christoph Wiltschke; Heimo Breiteneder; Hubert Pehamberger; Otto Scheiner; Ursula Wiedermann; Christoph C Zielinski
Inhibition of tumor cell growth by antibodies induced after vaccination with peptides derived from the extracellular domain of Her-2/neu.
International journal of cancer. Journal international du cancer 2003;107(6):976-83.
2003: Thomas Muster; Andrea Waltenberger; Andreas Grassauer; Sonja Hirschl; Peri Caucig; Ingrid Romirer; Dagmar Födinger; Heide Seppele; Oliver Schanab; Christine Magin-Lachmann; Roswitha Löwer; Burkhard Jansen; Hubert Pehamberger; Klaus Wolff
An endogenous retrovirus derived from human melanoma cells.
Cancer research 2003;63(24):8735-41.
2003: Alexandra Harbauer; Michael Binder; Hubert Pehamberger; Klaus Wolff; Harald Kittler
Validity of an unsupervised self-administered questionnaire for self-assessment of melanoma risk.
Melanoma research 2003;13(5):537-42.
2003: Christine Pirker; Klaus Holzmann; Sabine Spiegl-Kreinecker; Leonilla Elbling; Christiane Thallinger; Hubert Pehamberger; Michael Micksche; Walter Berger
Chromosomal imbalances in primary and metastatic melanomas: over-representation of essential telomerase genes.
Melanoma research 2003;13(5):483-92.
2003: Christiane Thallinger; Markus F Wolschek; Volker Wacheck; Helmut Maierhofer; Patrick Günsberg; Peter Polterauer; Hubert Pehamberger; Brett P Monia; Edgar Selzer; Klaus Wolff; Burkhard Jansen
Mcl-1 antisense therapy chemosensitizes human melanoma in a SCID mouse xenotransplantation model.
The Journal of investigative dermatology 2003;120(6):1081-6.
2003: Ligia Teban; Hubert Pehamberger; Klaus Wolff; Michael Binder; Harald Kittler
[Clinical value of a dermatoscopic classification of Clark nevi].
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2003;1(4):292-6.
2003: Monika Heidemarie Seltenhammer; Hubert Simhofer; S Scherzer; R Zechner; Ino Curik; Johann Sölkner; S M Brandt; Burkhard Jansen; Hubert Pehamberger; E Eisenmenger
Equine melanoma in a population of 296 grey Lipizzaner horses.
Equine veterinary journal 2003;35(2):153-7.
2003: Barbara Rosado; Scott W Menzies; Alexandra Harbauer; Hubert Pehamberger; Klaus Wolff; Michael Binder; Harald Kittler
Accuracy of computer diagnosis of melanoma: a quantitative meta-analysis.
Archives of dermatology 2003;139(3):361-7; discussion 366.
2003: Volker Wacheck; Doris Losert; Patrick Günsberg; Hans-Peter Vornlocher; Philipp Hadwiger; Anke Geick; Hubert Pehamberger; Markus Müller; Burkhard Jansen
Small interfering RNA targeting bcl-2 sensitizes malignant melanoma.
Oligonucleotides 2003;13(5):393-400.
2002: Edgar Selzer; Christiane Thallinger; Christoph Hoeller; Philipp Oberkleiner; Volker Wacheck; Hubert Pehamberger; Burkhard Jansen
Betulinic acid-induced Mcl-1 expression in human melanoma--mode of action and functional significance.
Molecular medicine (Cambridge, Mass.) 2002;8(12):877-84.
2002: Volker Wacheck; Clemens Krepler; Sabine Strommer; Elisabeth Heere-Ress; Robert Klem; Hubert Pehamberger; Hans-Georg Eichler; Burkhard Jansen
Antitumor effect of G3139 Bcl-2 antisense oligonucleotide is independent of its immune stimulation by CpG motifs in SCID mice.
Antisense & nucleic acid drug development 2002;12(6):359-67.
2002: Christine Hafner; Ursula Samwald; Stefan Wagner; Franco Felici; Elisabeth Heere-Ress; Erika Jensen-Jarolim; Klaus Wolff; Otto Scheiner; Hubert Pehamberger; Heimo Breiteneder
Selection of mimotopes of the cell surface adhesion molecule Mel-CAM from a random pVIII-28aa phage peptide library.
The Journal of investigative dermatology 2002;119(4):865-9.
2002: Patrick Guensberg; Volker Wacheck; Trevor Lucas; Brett P Monia; Hubert Pehamberger; Hans-Georg Eichler; Burkhard Jansen
Bcl-xL antisense oligonucleotides chemosensitize human glioblastoma cells.
Chemotherapy 2002;48(4):189-95.
2002: Markus Dawid; Hubert Pehamberger; Klaus Wolff; Michael Binder; Harald Kittler
Evaluation of the ability of patients to identify enlarging melanocytic nevi.
Archives of dermatology 2002;138(7):984-5.
2002: Edgar Selzer; I Okamoto; Trevor Lucas; Reinhard Kodym; Hubert Pehamberger; Burkhard Jansen
Protein kinase C isoforms in normal and transformed cells of the melanocytic lineage.
Melanoma research 2002;12(3):201-9.
2002: Elisabeth Heere-Ress; Christiane Thallinger; Trevor Lucas; Hermine Schlagbauer-Wadl; Volker Wacheck; Brett P Monia; Klaus Wolff; Hubert Pehamberger; Burkhard Jansen
Bcl-X(L) is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy.
International journal of cancer. Journal international du cancer 2002;99(1):29-34.
2002: Edgar Selzer; Volker Wacheck; Trevor Lucas; Elisabeth Heere-Ress; Min Wu; Katherine N Weilbaecher; Werner Schlegel; Peter Valent; Fritz Wrba; Hubert Pehamberger; David Fisher; Burkhard Jansen
The melanocyte-specific isoform of the microphthalmia transcription factor affects the phenotype of human melanoma.
Cancer research 2002;62(7):2098-103.
2002: Harald Kittler; Hubert Pehamberger; Klaus Wolff; Michael Binder
Diagnostic accuracy of dermoscopy.
The lancet oncology 2002;3(3):159-65.
2002: Hubert Pehamberger
Perspectives of pegylated interferon use in dermatological oncology.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2002;160():158-64.
2001: Michael Bergmann; Ingrid Romirer; Monika Sachet; R Fleischhacker; Adolfo García-Sastre; Peter Palese; Klaus Wolff; Hubert Pehamberger; Raimund Jakesz; Thomas Muster
A genetically engineered influenza A virus with ras-dependent oncolytic properties.
Cancer research 2001;61(22):8188-93.
2001: Christian Joukhadar; Nikolas Klein; Robert M Mader; Claudia Schrolnberger; Blanka Rizovski; Elisabeth Heere-Ress; Hubert Pehamberger; N Strauchmann; Burkhard Jansen; Markus Müller
Penetration of dacarbazine and its active metabolite 5-aminoimidazole-4-carboxamide into cutaneous metastases of human malignant melanoma.
Cancer 2001;92(8):2190-6.
2001: Robert Strohal; R Mosser; Harald Kittler; Klaus Wolff; Burkhard Jansen; Christine Brna; Georg Stingl; Hubert Pehamberger
MART-1/Melan-A and tyrosinase transcripts in peripheral blood of melanoma patients: PCR analyses and follow-up testing in relation to clinical stage and disease progression.
Melanoma research 2001;11(5):543-8.
2001: Christoph Hoeller; Burkhard Jansen; Elisabeth Heere-Ress; T Pustelnik; Ulrike Mossbacher; Hermine Schlagbauer-Wadl; Klaus Wolff; Hubert Pehamberger
Perilesional injection of r-GM-CSF in patients with cutaneous melanoma metastases.
The Journal of investigative dermatology 2001;117(2):371-4.
2001: Harald Kittler; R Weitzdorfer; Hubert Pehamberger; Klaus Wolff; Michael Binder
Compliance with follow-up and prognosis among patients with thin melanomas.
European journal of cancer (Oxford, England : 1990) 2001;37(12):1504-9.
2001: K Güven; Harald Kittler; Klaus Wolff; Hubert Pehamberger
Cisplatin and carboplatin combination as second-line chemotherapy in dacarbazine-resistant melanoma patients.
Melanoma research 2001;11(4):411-5.
2001: Dieter Fink; Hermine Schlagbauer-Wadl; Edgar Selzer; Trevor Lucas; Klaus Wolff; Hubert Pehamberger; Hans-Georg Eichler; Burkhard Jansen
Elevated procaspase levels in human melanoma.
Melanoma research 2001;11(4):385-93.
2001: Trevor Lucas; Barbara Pratscher; S Krishnan; Dieter Fink; Patrick Günsberg; Markus F Wolschek; Volker Wacheck; Thomas Muster; Ingrid Romirer; Klaus Wolff; Hubert Pehamberger; Hans-Georg Eichler; V M Rangnekar; Burkhard Jansen
Differential expression levels of Par-4 in melanoma.
Melanoma research 2001;11(4):379-83.
2001: Harald Kittler; Michael Binder; Klaus Wolff; Hubert Pehamberger
A ten-year analysis of demographic trends for cutaneous melanoma: analysis of 2501 cases treated at the University Department of Dermatology in Vienna (1990-1999).
Wiener klinische Wochenschrift 2001;113(9):321-7.
2000: Michael Binder; Harald Kittler; Stephan Dreiseitl; H Ganster; Klaus Wolff; Hubert Pehamberger
Computer-aided epiluminescence microscopy of pigmented skin lesions: the value of clinical data for the classification process.
Melanoma research 2000;10(6):556-61.
2000: Burkhard Jansen; Volker Wacheck; Elisabeth Heere-Ress; Hermine Schlagbauer-Wadl; Christoph Hoeller; Trevor Lucas; M Hoermann; Ursula Hollenstein; Klaus Wolff; Hubert Pehamberger
Chemosensitisation of malignant melanoma by BCL2 antisense therapy.
Lancet 2000;356(9243):1728-33.
2000: Edgar Selzer; Volker Wacheck; Reinhard Kodym; Hermine Schlagbauer-Wadl; Werner Schlegel; Hubert Pehamberger; Burkhard Jansen
Erythropoietin receptor expression in human melanoma cells.
Melanoma research 2000;10(5):421-6.
2000: Harald Kittler; Hubert Pehamberger; Klaus Wolff; Michael Binder
Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi.
Journal of the American Academy of Dermatology 2000;43(3):467-76.
2000: Michael Bergmann; Adolfo Garcia-Sastre; E Carnero; Hubert Pehamberger; Klaus Wolff; Peter Palese; Thomas Muster
Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication.
Journal of virology 2000;74(13):6203-6.
2000: Edgar Selzer; E Pimentel; Volker Wacheck; Werner Schlegel; Hubert Pehamberger; Burkhard Jansen; Reinhard Kodym
Effects of betulinic acid alone and in combination with irradiation in human melanoma cells.
The Journal of investigative dermatology 2000;114(5):935-40.
2000: Hermine Schlagbauer-Wadl; Gabriele Klosner; Elisabeth Heere-Ress; Stefan Waltering; Ingrid Moll; Klaus Wolff; Hubert Pehamberger; Burkhard Jansen
Bcl-2 antisense oligonucleotides (G3139) inhibit Merkel cell carcinoma growth in SCID mice.
The Journal of investigative dermatology 2000;114(4):725-30.
2000: Harald Kittler; M Seltenheim; Markus Dawid; Hubert Pehamberger; Klaus Wolff; Michael Binder
Frequency and characteristics of enlarging common melanocytic nevi.
Archives of dermatology 2000;136(3):316-20.
1999: Burkhard Jansen; Hermine Schlagbauer-Wadl; H Kahr; Elisabeth Heere-Ress; Bernhard X Mayer; H Eichler; Hubert Pehamberger; Mali Gana-Weisz; E Ben-David; Yoel Kloog; Klaus Wolff
Novel Ras antagonist blocks human melanoma growth.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(24):14019-24.
1999: Burkhard Jansen; Elisabeth Heere-Ress; Hermine Schlagbauer-Wadl; Julius Halaschek-Wiener; Stefan Waltering; Ingrid Moll; Hubert Pehamberger; Daniele Marciano; Yoel Kloog; Klaus Wolff
Farnesylthiosalicylic acid inhibits the growth of human Merkel cell carcinoma in SCID mice.
Journal of molecular medicine (Berlin, Germany) 1999;77(11):792-7.
1999: Hermine Schlagbauer-Wadl; Burkhard Jansen; M Müller; P Polterauer; Klaus Wolff; Hans-Georg Eichler; Hubert Pehamberger; E Konak; J P Johnson
Influence of MUC18/MCAM/CD146 expression on human melanoma growth and metastasis in SCID mice.
International journal of cancer. Journal international du cancer 1999;81(6):951-5.
1999: S Schreiber; E Kämpgen; Ernst Wagner; D Pirkhammer; J Trcka; H Korschan; A Lindemann; Roland Dorffner; Harald Kittler; F Kasteliz; Z Küpcü; A Sinski; Kurt Zatloukal; Michael Buschle; Walter Schmidt; Max L Birnstiel; RE Kempe; T Voigt; H A Weber; Hubert Pehamberger; Roland Mertelsmann; Eva-B Bröcker; Klaus Wolff; Georg Stingl
Immunotherapy of metastatic malignant melanoma by a vaccine consisting of autologous interleukin 2-transfected cancer cells: outcome of a phase I study.
Human gene therapy 1999;10(6):983-93.
1999: Harald Kittler; M Seltenheim; Markus Dawid; Hubert Pehamberger; Klaus Wolff; Michael Binder
Morphologic changes of pigmented skin lesions: a useful extension of the ABCD rule for dermatoscopy.
Journal of the American Academy of Dermatology 1999;40(4):558-62.
1999: Walter Tschugguel; T Pustelnik; Harald Lass; Michael Mildner; Wolfgang Weninger; Christian Schneeberger; Burkhard Jansen; Erwin Tschachler; Thomas Waldhör; Johannes C Huber; Hubert Pehamberger
Inducible nitric oxide synthase (iNOS) expression may predict distant metastasis in human melanoma.
British journal of cancer 1999;79(9-10):1609-12.
1999: Hermine Schlagbauer-Wadl; Marieke Griffioen; A van Elsas; Peter I Schrier; T Pustelnik; Hans-Georg Eichler; Klaus Wolff; Hubert Pehamberger; Burkhard Jansen
Influence of increased c-Myc expression on the growth characteristics of human melanoma.
The Journal of investigative dermatology 1999;112(3):332-6.
1999: M Binder; Harald Kittler; Hubert Pehamberger; Klaus Wolff
Possible hazard to patients from immersion oil used for epiluminescence microscopy.
Journal of the American Academy of Dermatology 1999;40(3):499.
1999: Michael Binder; Harald Kittler; Andreas Steiner; Markus Dawid; Hubert Pehamberger; Klaus Wolff
Reevaluation of the ABCD rule for epiluminescence microscopy.
Journal of the American Academy of Dermatology 1999;40(2 Pt 1):171-6.
1999: I Okamoto; Hendrati Pirc-Danoewinata; Jutta Ackermann; Johannes Drach; Hermine Schlagbauer-Wadl; Burkhard Jansen; Klaus Wolff; Hubert Pehamberger; Christine Marosi
Deletions of the region 17p11-13 in advanced melanoma revealed by cytogenetic analysis and fluorescence in situ hybridization.
British journal of cancer 1999;79(1):131-7.
1998: Arno Seeber; Michael Binder; Andreas Steiner; Klaus Wolff; Hubert Pehamberger
Treatment of metastatic malignant melanoma with dacarbazine plus fotemustine.
European journal of cancer (Oxford, England : 1990) 1998;34(13):2129-31.
1998: Robert Strohal; Christine Brna; Ulrike Mossbacher; Gottfried Fischer; Hubert Pehamberger; Georg Stingl
First comparative delineation of the T cell receptor repertoire in primary and multiple subsequent/coexisting metastatic melanoma sites.
The Journal of investigative dermatology 1998;111(6):1085-91.
1998: Michael Binder; Andreas Steiner; Ulrike Mossbacher; M Hunegnaw; Hubert Pehamberger; Klaus Wolff
Estimation of the volume-weighted mean nuclear volume discriminates keratoacanthoma from squamous cell carcinoma.
The American Journal of dermatopathology 1998;20(5):453-8.
1998: Susan Meghdadi; Georgios Karanikas; Hermine Schlagbauer-Wadl; Burkhard Jansen; Fahdi Chehne; Margarida Rodrigues; Hubert Pehamberger; Helmut Sinzinger
Technetium-99m-tetrofosmin: a new agent for melanoma imaging?
Anticancer research 1998;18(4A):2759-62.
1998: Michael Binder; Harald Kittler; Arno Seeber; Andreas Steiner; Hubert Pehamberger; Klaus Wolff
Epiluminescence microscopy-based classification of pigmented skin lesions using computerized image analysis and an artificial neural network.
Melanoma research 1998;8(3):261-6.
1998: Harald Kittler; M Seltenheim; Hubert Pehamberger; Klaus Wolff; Michael Binder
Diagnostic informativeness of compressed digital epiluminescence microscopy images of pigmented skin lesions compared with photographs.
Melanoma research 1998;8(3):255-60.
1998: Edgar Selzer; Hermine Schlagbauer-Wadl; I Okamoto; Hubert Pehamberger; R Pötter; Burkhard Jansen
Expression of Bcl-2 family members in human melanocytes, in melanoma metastases and in melanoma cell lines.
Melanoma research 1998;8(3):197-203.
1998: Hubert Pehamberger; Hans Peter Soyer; Andreas Steiner; R Kofler; M Binder; Paul Mischer; Wolf Pachinger; J Auböck; Peter Fritsch; H Kerl; Klaus Wolff
Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma. Austrian Malignant Melanoma Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1425-9.
1998: Burkhard Jansen; Hermine Schlagbauer-Wadl; B D Brown; R N Bryan; A van Elsas; Markus Müller; Klaus Wolff; Hans-Georg Eichler; Hubert Pehamberger
bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice.
Nature medicine 1998;4(2):232-4.
1997: Michael Binder; Harald Kittler; Andreas Steiner; Roland Dorffner; Klaus Wolff; Hubert Pehamberger
Lymph node sonography versus palpation for detecting recurrent disease in patients with malignant melanoma.
European journal of cancer (Oxford, England : 1990) 1997;33(11):1805-8.
1997: Margot Püspök-Schwarz; Andreas Steiner; Michael Binder; B Partsch; Klaus Wolff; Hubert Pehamberger
Statistical evaluation of epiluminescence microscopy criteria in the differential diagnosis of malignant melanoma and pigmented basal cell carcinoma.
Melanoma research 1997;7(4):307-11.
1997: Michael Binder; Andreas Steiner; Ulrike Mossbacher; M Hunegnaw; Klaus Wolff; Hubert Pehamberger
Quantification of vascularity in nodular melanoma and Spitz's nevus.
Journal of cutaneous pathology 1997;24(5):272-7.
1997: Michael Binder; M Puespoeck-Schwarz; Andreas Steiner; Harald Kittler; M Muellner; Klaus Wolff; Hubert Pehamberger
Epiluminescence microscopy of small pigmented skin lesions: short-term formal training improves the diagnostic performance of dermatologists.
Journal of the American Academy of Dermatology 1997;36(2 Pt 1):197-202.
1997: Burkhard Jansen; Hermine Schlagbauer-Wadl; Hans-Georg Eichler; Klaus Wolff; A van Elsas; Peter I Schrier; Hubert Pehamberger
Activated N-ras contributes to the chemoresistance of human melanoma in severe combined immunodeficiency (SCID) mice by blocking apoptosis.
Cancer research 1997;57(3):362-5.
1996: B Partsch; M Binder; M Püspök-Schwarz; Klaus Wolff; Hubert Pehamberger
Limitations of high frequency ultrasound in determining the invasiveness of cutaneous malignant melanoma.
Melanoma research 1996;6(5):395-8.
1996: Burkhard Jansen; S A Inoue; H Wadl; Hans-Georg Eichler; Klaus Wolff; A van Elsas; Peter I Schrier; Hubert Pehamberger
N-ras oncogene expression changes the growth characteristics of human melanoma in two independent SCID-hu mouse models.
International journal of cancer. Journal international du cancer 1996;67(6):821-5.
1996: K Addo-Boadu; J Wojta; G Christ; P Hufnagl; Hubert Pehamberger; B R Binder
Azelaic acid decreases the fibrinolytic potential of cultured human melanoma cells in vitro.
Cancer letters 1996;103(2):125-9.
1996: Ulrike Mossbacher; S Knollmayer; M Binder; Andreas Steiner; Klaus Wolff; Hubert Pehamberger
Increased nuclear volume in metastasizing "thick" melanomas.
The Journal of investigative dermatology 1996;106(3):437-40.
1995: M Binder; M Schwarz; A Winkler; Andreas Steiner; A Kaider; Klaus Wolff; Hubert Pehamberger
Epiluminescence microscopy. A useful tool for the diagnosis of pigmented skin lesions for formally trained dermatologists.
Archives of dermatology 1995;131(3):286-91.
1995: B Jansen; H Wadl; S A Inoue; B Trülzsch; Edgar Selzer; Michael Duchêne; H G Eichler; K Wolff; Hubert Pehamberger
Phosphorothioate oligonucleotides reduce melanoma growth in a SCID-hu mouse model by a nonantisense mechanism.
Antisense research and development 1995;5(4):271-7.
1994: Robert Strohal; L Paucz; Hubert Pehamberger; Georg Stingl
T-cell receptor repertoire of lymphocytes infiltrating cutaneous melanoma is predominated by V alpha specificities present in T-cells of normal human skin.
Cancer research 1994;54(17):4734-9.
1994: M Binder; Andreas Steiner; M Schwarz; S Knollmayer; Klaus Wolff; Hubert Pehamberger
Application of an artificial neural network in epiluminescence microscopy pattern analysis of pigmented skin lesions: a pilot study.
The British journal of dermatology 1994;130(4):460-5.
1994: Andreas Steiner; M Binder; Ulrike Mossbacher; Klaus Wolff; Hubert Pehamberger
Estimation of the volume-weighted mean nuclear volume discriminates Spitz's nevi from nodular malignant melanomas.
Laboratory investigation; a journal of technical methods and pathology 1994;70(3):381-5.
1994: Klaus Wolff; M Binder; Hubert Pehamberger
Epiluminescence microscopy: a new approach to the early detection of melanoma.
Advances in dermatology 1994;9():45-56; discussion 57.
1994: Robert Strohal; K Marberger; Hubert Pehamberger; Georg Stingl
Immunohistological analysis of anti-melanoma host responses.
Archives of dermatological research 1994;287(1):28-35.
1993: Christine Marosi; Manfred Muhm; A Argyriou-Tirita; Hubert Pehamberger; Hendrati Pirc-Danoewinata; Klaus Geissler; Gottfried J Locker; N Grois; Oskar A Haas
Tetrasomy 8 in acute monoblastic leukemia (AML-M5a) with myelosarcomatosis of the skin.
Cancer genetics and cytogenetics 1993;71(1):50-4.
1993: Andreas Steiner; M Binder; M Schemper; Klaus Wolff; Hubert Pehamberger
Statistical evaluation of epiluminescence microscopy criteria for melanocytic pigmented skin lesions.
Journal of the American Academy of Dermatology 1993;29(4):581-8.
1993: Robert Strohal; Klemens Rappersberger; Hubert Pehamberger; Klaus Wolff
Nonbullous pemphigoid: prodrome of bullous pemphigoid or a distinct pemphigoid variant?
Journal of the American Academy of Dermatology 1993;29(2 Pt 2):293-9.
1993: Hubert Pehamberger; M Binder; Andreas Steiner; Klaus Wolff
Early recognition and prognostic markers of melanoma.
Melanoma research 1993;3(4):279-84.
1993: Hubert Pehamberger; M Binder; S Knollmayer; Klaus Wolff
Immediate effects of a public education campaign on prognostic features of melanoma.
Journal of the American Academy of Dermatology 1993;29(1):106-9.
1993: Hubert Pehamberger; M Binder; Andreas Steiner; Klaus Wolff
In vivo epiluminescence microscopy: improvement of early diagnosis of melanoma.
The Journal of investigative dermatology 1993;100(3):356S-362S.
1992: Andreas Steiner; Hubert Pehamberger; M Binder; Klaus Wolff
Pigmented Spitz nevi: improvement of the diagnostic accuracy by epiluminescence microscopy.
Journal of the American Academy of Dermatology 1992;27(5 Pt 1):697-701.
1992: M Binder; I Dolezal; Klaus Wolff; Hubert Pehamberger
Stereologic estimation of volume-weighted mean nuclear volume as a predictor of prognosis in "thin" malignant melanoma.
The Journal of investigative dermatology 1992;99(2):180-3.
1992: M Binder; A Winkler; Roland Dorffner; E Glebowski; Klaus Wolff; Hubert Pehamberger
Fotemustine plus dacarbazine in advanced stage III malignant melanoma.
European journal of cancer (Oxford, England : 1990) 1992;28A(11):1814-6.
1991: Andreas Steiner; Klemens Rappersberger; Veronika Groh; Hubert Pehamberger
Diffuse melanosis in metastatic malignant melanoma.
Journal of the American Academy of Dermatology 1991;24(4):625-8.
1990: M Binder; Hubert Pehamberger; Andreas Steiner; Klaus Wolff
Elective regional lymph node dissection in malignant melanoma.
European journal of cancer (Oxford, England : 1990) 1990;26(8):871-3.
1990: L Prayer; H Winkelbauer; N Gritzmann; FW Winkelbauer; M Helmer; Hubert Pehamberger
Sonography versus palpation in the detection of regional lymph-node metastases in patients with malignant melanoma.
European journal of cancer (Oxford, England : 1990) 1990;26(7):827-30.
1989: L Prayer; FW Winkelbauer; N Gritzmann; H Weislein; M Helmer; Hubert Pehamberger
[Primary lymph node metastases in malignant melanoma studied via high-resolution real-time sonography--its value and indications].
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 1989;151(3):294-7.
1989: C Wolf; Hubert Pehamberger; S Breyer; K M Leiferman; Klaus Wolff
Episodic angioedema with eosinophilia.
Journal of the American Academy of Dermatology 1989;20(1):21-7.
1988: Andreas Steiner; K Konrad; Hubert Pehamberger; Klaus Wolff
Verrucous malignant melanoma.
Archives of dermatology 1988;124(10):1534-7.
1987: Andreas Steiner; Hubert Pehamberger; Klaus Wolff
In vivo epiluminescence microscopy of pigmented skin lesions. II. Diagnosis of small pigmented skin lesions and early detection of malignant melanoma.
Journal of the American Academy of Dermatology 1987;17(4):584-91.
1987: Hubert Pehamberger; Andreas Steiner; Klaus Wolff
In vivo epiluminescence microscopy of pigmented skin lesions. I. Pattern analysis of pigmented skin lesions.
Journal of the American Academy of Dermatology 1987;17(4):571-83.
1985: H Leibl; Georg Stingl; Hubert Pehamberger; H Korschan; K Konrad; Klaus Wolff
Inhibition of DNA synthesis of melanoma cells by azelaic acid.
The Journal of investigative dermatology 1985;85(5):417-22.